RARuslan V. Andreev

Ruslan V. Andreev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruslan V. Andreev has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ischemic stroke in combat conditions. Vasculocerebral injury

    by Igor V. Litvinenko, Nikolay V. Tsygan, Sergey V. Kolomentsev, Sergey Yu. Golokhvastov, Ruslan V. Andreev, Miroslav M. Odinak, Dmitriy V. Svistov, Aleksandr V. Savello, Kirill V. Kitachev, Vasiliy O. Nikishin, et al.

    During armed conflicts, the incidence of ischemic stroke among military personnel increases substantially compared with peacetime. In addition to the elevated risk of combat-related injuries, military service members are exposed to intense physical and emotional stress and extreme environmental factors, which contribute to the toll of both common (atherosclerotic arterial changes, diabetes mellitus, obesity, cardiovascular diseases) and specific risk factors more typical of young adults (cardiac sources of embolism, non-inflammatory and inflammatory arteriopathies, coagulation disorders), as well as generate additional stroke risk factors unique to combat conditions. Firearm injuries have a special place in the pathogenesis of combat-related ischemic stroke. We have proposed and substantiated the term vasculocerebral injury. It is a distinct type of combat firearm injury, representing a cascade of sequential interrelated pathological changes occurring in the damaged major precerebral arteries (aorta, brachiocephalic trunk, common and internal carotid arteries, vertebral arteries), cerebral arteries, their vascular territories, blood cellular elements, and surrounding tissues as a result of the complex damaging effect of a high-energy projectile (shock wave, lateral impact energy, vortex flow), ultimately leading to pathophysiologically heterogeneous secondary acute cerebrovascular lesions, including ischemic stroke. Clinical cases of vasculocerebral injury are presented. Early identification of cervical and cranial vascular injuries contributes to timely and optimal treatment tactic selection (surgical, conservative, including differentiated antithrombotic therapy) and improves ischemic stroke prevention during combat operations.


  • Cognitive impairment after major surgical operations

    by N.V. Tsygan, O.S. Sandalova, V.A. Yakovleva, A.V. Ryabtsev, R.V. Andreev, K.V. Sapozhnikov, M.M. Odinak, I.V. Litvinenko

    Objective. To study the characteristics of cognitive impairment after extensive surgical operations of various profiles, to develop tactics of cerebroprotection, as well as personalized prevention of cognitive impairment (CI). Material and methods. The study included 277 patients who underwent elective extensive cardiac surgery (coronary bypass surgery, prosthetics of the aortic heart valve) and oncological (for malignant neoplasms of the thoracic or abdominal cavities) profile. All patients underwent a comprehensive clinical, laboratory, and instrumental examination (including neuropsychological testing using the MoCA, FAB scales) in the preoperative and intraoperative periods, as well as 10 days after surgery. Results. Deferred CI after cardiac surgery was diagnosed in 30—36% of patients, and after oncological surgery in 31% of patients. The incidence of acute clinical types of postoperative cerebral dysfunction also had no statistically significant differences: perioperative stroke (2—4% and 2%), symptomatic delirium of the early postoperative period (14—17% and 11%, respectively). Postoperative brain dysfunction was diagnosed after 44% of cardiac surgeries and 34% of oncosurgical operations. Risk factors for deferred CI after coronary bypass surgery: age over 65 years; stenotic atherosclerosis of the brachiocephalic arteries. During aortic valve replacement, the risk factors for deferred CI are: total cholesterol >5.1 mmol/L; very low-density lipoproteins >1.2 mmol/L; low-density lipoproteins >3.2 mmol/L; platelet count5 points; ASA physical status >Class III; MoCA test scores<20 points. Conclusion. Most of the risk factors for deferred cognitive impairment are preoperative, which allows ahead additional assessment of the possibility of modifying the surgical technique and accompanying therapy, as well as designing of personalized tactics of cerebroprotection and prevention of cognitive impairment.


  • Open Access

    Brait–Fahn–Schwarz disease (result of two-year clinical follow-up)

    by P. S. Dynin, I. V. Litvinenko, A. Yu. Emelin, I. N. Samartsev, R. V. Andreev, I. V. Lepekhin, K. M. Naumov

    The article presents the result of a two-year follow-up of a patient with a combination of parkinsonism syndromes and amyotrophic lateral sclerosis, a rare form of a neurodegenerative disease of the central nervous system called “Bright–Fan–Schwarz disease”. The diversity and polymorphism of symptoms in this disease can lead to diffi culties in diagnosis and therapy. The data of the patient’s anamnesis, the dynamics of the clinical picture during the stay in the hospital, the diagnostic and therapeutic measures taken, and the subsequent follow-up are given. In conclusion, a generalization of the features of the clinical picture and the progression of the disease in question is presented.

  • Delirium in cardiac surgery: epidemiology, pathogenesis and prevention highlights (Review)

    by Nikolay V. Tsygan, Aleksandr V. Ryabtsev, Olga S. Sandalova, Ruslan V. Andreev, Aleksandr P. Trashkov, Andrey S. Peleshok, Evgeniy S. Kurasov, Igor V. Litvinenko, Цыган Николай Васильевич

    Symptomatic delirium of the early postoperative period is a qualitative disorder (clouding) of consciousness that is deferred, occurs under mainly vascular, inflammatory and metabolic alterations, manifests by variant behavioral disorders. Three clinical studies were conducted to assess the state of the brain after the most frequent elective cardiac surgery coronary bypass surgery, open-heart valve surgery, open-heart and endovascular aortic valve surgery. 306 patients were included in the listed studies, the controls included the results of the examination of 120 patients who underwent elective eversion carotid endarterectomy and 15 patients who underwent elective abdominal aortic prosthetics. Thus, 441 patients underwent perioperative neurological examination according to a single algorithm. According to the results of the conducted studies, the frequency of symptomatic delirium of the early postoperative period during elective cardiac surgery is 1214%. Symptomatic delirium of the early postoperative period commonly develops 13 days after surgery, the average duration is from 1 to 3 days. Symptomatic delirium of the early postoperative period also increases the likelihood of subsequent development of other clinical types of postoperative cerebral dysfunction perioperative stroke and deferred cognitive impairment. Most of the symptomatic delirium of the early postoperative period risk factors are preoperative and have vascular origin. Combined use of CAM-ICU and RASS scales is recommended for screening diagnostics of symptomatic delirium of the early postoperative period. The increase of the number of cardiac surgeries demonstrates the necessity of the further improvement of perioperative cerebroprotection, the main directions are promptly diagnosis and correction of risk factors, as well as the use of non-pharmacological and pharmacological methods of brain protection, including the original four-component (inosine, nicotinamide, riboflavin, succinic acid) neuroprotector with cytoprotective and antihypoxic effects, as well as meglumine sodium succinate with antihypoxic and anti-inflammatory effects.

  • Open Access

    Тhe clinical case of benign monomelic amyotrophy of the lower limb

    by R. V. Andreev, A. V. Smolyannikova, S. Yu. Golokhvastov, A. Yu. Emelin, V. Yu. Lobzin, I. V. Litvinenko, N. V. Tsygan, D. N. Frunza, M. N. Markova, N. A. Lupina

    The benign monomelic amyotrophy of the lower limb is a slowly progressive disease that is clinically manifested by muscle atrophy in only one lower limb. This disease is quite rare, while it is most common in Asian countries (about 80 cases have been described). According to the literature a total of 16 cases of benign monomelic amyotrophy of the lower limb were described in Europe by 2000. Etiology and pathogenesis have not been reliably studied now. The article presents a clinical case of the development of this disease in a 42-year-old patient. The patient was admitted with complaints of weakness in the right leg and its decrease in volume. During the period of hospitalization, diff erential diagnosis was carried out with amyotrophic lateral sclerosis, progressive muscle atrophy, Hirayama disease, vascular and paraneoplastic processes. According to the results of a comprehensive laboratory and instrumental examination, the diagnosis was fi rst established: benign monomelic amyotrophy of the lower limb. The father of a patient who had atrophy of the muscles of the left lower limb would also be examined. According to the data of hereditary anamnesis, an assumption was made about the presence of the phenomenon of anticipation in the inheritance of benign monomelic amyotrophy of the lower limb. This article describes for the fi rst time a case of benign monomelic amyotrophy of the lower limb in the domestic literature, as well as a familial case of this disease all over the world.

  • Open Access

    The algorithm of reperfusion treatment of the ischemic stroke: focus on DAWN and DEFUSE-3 trials

    by I. V. Litvinenko, M. M. Odinak, A. V. Ryabtsev, S. N. Yanishevsky, S. Yu. Golokhvastov, S. V. Kolomentsev, R. V. Andreev, N. V. Tsygan

    The history of reperfusion treatment for ischemic stroke was officially recognized in 1996, when the use of systemic thrombolytic therapy (TLT) was authorized in the United States of America and the first clinical guidelines were published (American Heart Association (AHA) Stroke Council). The use of TLT for the treatment of ischemic stroke in the Russian Federation began in 2005–2006. The next step was the development of endovascular reperfusion techniques (2005) following the presentation of the results of the MERCI study, which evaluated the safety and efficacy of microconductors for fragmentation and destruction of blood clots. Currently, neurologists working with patients with acute cerebrovascular accidents are guided by national regulatory documents — order of the Ministry of Health of the Russian Federation dated by November 15, 2012 No. 928n “On approval of the Procedure for providing medical care to patients with acute cerebrovascular accidents” and the Protocol of reperfusion therapy acute ischemic stroke (2019), which provide basic information on the methods of diagnosis and treatment of ischemic cerebral stroke, as well as international recommendations ESO, AHA/ASA, which provide grounds for increasing therapeutic options, in particular by extending the time of the “therapeutic window”. The authors of article created the algorithm for reperfusion therapy for ischemic stroke, based on the analysis and generalization of regulatory documents, clinical guidelines and the results of DAWN and DEFUSE-3 studies.